β-carbolines as neurotoxins

Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy

Volumn , Issue , 2012, Pages 77-103

  Herraiz, Tomás ^a  

^a INSTITUTE OF FOOD SCIENCE   (Spain)

Author keywords

B Carbolines; Cell culture; Cytochrome P450; Dopaminergic cell culture; Free radicals; MAO; Mitochondrial function; MPP+; MPTP; N methyltransferase; Neurotoxins; Tetrahydro carbolines

Indexed keywords

EID: 85009751409     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-1542-8_5     Document Type: Chapter

References (110)

1. Adachi J, Mizoi Y, Naito T, Ogawa Y, Uetani Y, Ninomiya I (1991) Identification of tetrahydro- beta-carboline-3-carboxylic acid in foodstuffs, human urine and human milk. J Nutr 121:646-652
2. Airaksinen MM, Kari I (1981a) Beta-carbolines, psychoactive compounds in the mammalian body. 2. Effects. Med Biol 59:190-211
3. Airaksinen MM, Kari I (1981b) Beta-Carbolines, psychoactive compounds in the mammalian body. Occurrence, origin and metabolism. Med Biol 59:21-34
4. Akundi RS, Macho A, Munoz E, Lieb K, Bringmann G, Clement HW, Hull M, Fiebich BL (2004) 1-Trichloromethyl--1,2,3,4-tetrahydro-beta-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH. J Neurochem 91:263-273
5. Albores R, Neafsey EJ, Drucker G, Fields JZ, Collins MA (1990) Mitochondrial respiratory inhibition by A-methylated beta-carboline derivatives structurally resembling N-methyl-4- phenylpyridine. Proc Natl Acad Sci USA 87:9368-9372
6. Anderson NJ, Tyacke RJ, Husbands SM, Nutt DJ, Hudson AL, Robinson ESJ (2006) In vitro and ex vivo distribution of H-3 harmane, an endogenous beta-carboline, in rat brain. Neuropharmacology 50:269-276
7. Aoyama K, Matsubara K, Okada K, Fukushima S, Shimizu K, Yamaguchi S, Uezono T, Satomi M, Hayase N, Ohta S, Shiono H, Kobayashi S (2000) A-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test. J Neural Transm 107:985-995
8. Barker SA, Harrison REW, Monti JA, Brown GB, Christian ST (1981) Identification and quantification of 1,2,3,4-tetrahydro-beta-carboline, 2-methyl-1,2,3,4-tetrahydro-beta-carboline, and 6-methoxy-1,2,3,4-tetrahydro-beta-carboline as in vivo constituents of rat brain and adrenal gland. Biochem Pharmacol 30:9-17
9. Beck O, Repke DB, Faull KF (1986) 6-Hydroxymethtryptoline is naturally-occurring in mammalian urine. Identification by combined chiral capillary gas chromatography and high resolution mass spectrometry. Biomed Environ Mass Spectrom 13:469-472
10. Bonnet R, Pavlovic S, Lehmann J, Rommelspacher H (2004) The strong inhibition of triosephos- phate isomerase by the natural beta-carbolines may explain their neurotoxic actions. Neuroscience 127:443-453
11. Bringmann G, Friedrich H, Birner G, Koob M, Sontag KH, Heim C, Kolasiewicz W, Fahr S, Stablein M, God R, Feineis D (1996) Endogenous alkaloids in man.26. Determination of the dopaminergic neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) in biological samples using gas chromatography with selected ion monitoring. J Chromatogr B 687:337-348
12. Bringmann G, Feineis D, God R, Peters K, Peters EM, Scholz J, Riederer F, Moser A (2002) 1-Trichloromethyl--1,2,3,4-tetrahydro-beta-carboline (TaClo) and related derivatives: Chemistry and biochemical effects on catecholamine biosynthesis. Bioorg Med Chem 10:2207-2214
13. Bringmann G, Feineis D, Munchbach M, God R, Peters K, Peters EM, Mossner R, Lesch KP (2006) Toxicity and metabolism of the chloral-derived mammalian alkaloid 1-trichloromethyl-1,2,3,4- tetrahydro-beta-carboline (TaClo) in PC12 cells. Z Naturforsch C 61:601-610
14. Buckholtz NS (1980) Neurobiology of tetrahydro-beta-carbolines. Life Sci 27:893-903
15. Cobuzzi RJ, Neafsey EJ, Collins MA (1994) Differential cytotoxicities of A-methyl-beta- carbolinium analogs of MPP+ in PC12 cells. Insights into potential neurotoxicants in Parkinson's disease. J Neurochem 62:1503-1510
16. Coleman T, Ellis SW, Martin IJ, Lennard MS, Tucker GT (1996) 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) is A-demethylated by cytochromes P450 2D6, 1A2 and 3A4. Implications for susceptibility to Parkinson's disease. J Pharmacol Exp Ther 277:685-690
17. Collins MA, Neafsey EJ (1985) Beta-Carboline analogs of A-methyl-4-phenyl-1,2,5,6- tetrahydropyridine (MPTP). Endogenous factors underlying idiopathic Parkinsonism. Neurosci Lett 55:179-184
18. Collins MA, Neafsey EJ (1998) Beta-carboline derivatives as neurotoxins. In: Moser EA (ed) Pharmacology of endogenous neurotoxins. Birkhauser, Boston, pp 129-149
19. Collins MA, Neafsey EJ, Matsubara K, Cobuzzi RJ, Rollema H (1992) Indole-A-methylated beta- carbolinium ions as potential brain bioactivated neurotoxins. Brain Res 570:154-160
20. Collins MA, Neafsey EJ, Matsubara K (1996) Beta-carbolines: metabolism and neurotoxicity. Biog Amines 12:171-180
21. Di Monte DA, Lavasani M, Manning-Bog AB (2002) Environmental factors in Parkinson's disease. Neurotoxicology 23:487-502
22. Drucker G, Raikoff K, Neafsey EJ, Collins MA (1990) Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of A-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) oxidation products. Brain Res 509:125-133
23. El Gendy MAM, El-Kadi AUS (2010) Harman induces CYP1A1 enzyme through an aryl hydrocarbon receptor mechanism. Toxicol Appl Pharmacol 249:55-64
24. Elbaz A, Levecque C, Clavel J, Vidal JS, Richard F, Amouyel P, Alperovitch A, Chartier-Harlin MC, Tzourio C (2004) CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease. Ann Neurol 55:430-434
25. Ergene E, Schoener EP (1993) Effects of harmane (1-Methyl-beta-carboline) on neurons in the nucleus accumbens of the rat. Pharmacol Biochem Behav 44:951-957
26. Fekkes D, Bode WT (1993) Occurrence and partition of the beta-carboline norharman in rat organs. Life Sci 52:2045-2054
27. Fekkes D, Schouten MJ, Pepplinkhuizen L, Bruinvels J, Lauwers W, Brinkman UA (1992) Norharman, a normal body constituent. Lancet 339:506
28. Fukushima S, Matsubara K, Akane A, Shiono H (1992) 1-Methyl-tetrahydro-beta-carboline-3- carboxylic acid is present in the rat brain and is not increased after acute ethanol injection with cyanamide treatment. Alcohol 9:31-35
29. Gearhart DA, Neafsey EJ, Collins MA (1997) Characterization of brain beta-carboline-2-A-meth- yltransferase, an enzyme that may play a role in idiopathic Parkinson's disease. Neurochem Res 22:113-121
30. Gearhart DA, Collins MA, Lee JM, Neafsey EJ (2000) Increased beta-carboline 9A-methyltransferase activity in the frontal cortex in Parkinson's disease. Neurobiol Dis 7:201-211
31. Gearhart DA, Neafsey EJ, Collins MA (2002a) Phenylethanolarnine A-methyltransferase has beta- carboline 2A-methyltransferase activity: hypothetical relevance to Parkinson's disease. Neurochem Int 40:611-620
32. Gearhart DA, Toole PF, Beach JW (2002b) Identification of brain proteins that interact with 2-methylnorharman: An analog of the parkinsonian-inducing toxin, MPP+. Neurosci Res 44:255-265
33. Gutsche B, Herderich M (1997) HPLC-MS/MS profiling of tryptophan-derived alkaloids in food: Identification of tetrahydro-beta-carbolinedicarboxylic acids. J Agric Food Chem 45:2458-2462
34. 2+ channels. Behav Brain Res 215:136-140
35. Hamann J, Rommelspacher H, Storch A, Reichmann H, Gille G (2006) Neurotoxic mechanisms of 2,9-dimethyl-beta-carbolinium ion in primary dopaminergic culture. J Neurochem 98:1185-1199
36. Hamann J, Wernicke C, Lehmann J, Reichmann H, Rommelspacher H, Gille G (2008) 9-Methyl- beta-carboline up-regulates the appearance of differentiated dopaminergic neurones in primary mesencephalic culture. Neurochem Int 52:688-700
37. Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC (1984) Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311:467-469
38. Herraiz T (1996) Occurrence of tetrahydro-beta-carboline-3-carboxylic acids in commercial foodstuffs. J Agric Food Chem 44:3057-3065
39. Herraiz T (2002) Identification and occurrence of the bioactive beta-carbolines norharman and harman in coffee brews. Food Addit Contam 19:748-754
40. Herraiz T (2004a) Relative exposure to beta-carbolines norharman and harman from foods and tobacco smoke. Food Addit Contam 21:1041-1050
41. Herraiz T (2004b) Tetrahydro-beta-carboline alkaloids in beverages and foods. ACS Symp Ser 871:405-426
42. Herraiz T (2007) Identification and occurrence of beta-carboline alkaloids in raisins and inhibition of monoamine oxidase (MAO). J Agric Food Chem 55:8534-8540
43. Herraiz T (2008) Beta-carboline alkaloids. In: Gilbert J, enyuva HZ (eds) Bioactive compounds in foods. Blackwell, Oxford, pp 199-218
44. Herraiz T, Chaparro C (2005) Human monoamine oxidase is inhibited by tobacco smoke: beta- carboline alkaloids act as potent and reversible inhibitors. Biochem Biophys Res Commun 326:378-386
45. Herraiz T, Chaparro C (2006) Human monoamine oxidase enzyme inhibition by coffee and beta- carbolines norharman and harman isolated from coffee. Life Sci 78:795-802
46. Herraiz T, Galisteo J (2003) Tetrahydro-beta-carboline alkaloids occur in fruits and fruit juices. Activity as antioxidants and radical scavengers. J Agric Food Chem 51:7156-7161
47. Herraiz T, Galisteo J (2004) Endogenous and dietary indoles: A class of antioxidants and radical scavengers in the ABTS assay. Free Radic Res 38:323-331
48. Herraiz T, Papavergou E (2004) Identification and occurrence of tryptamine- and tryptophan- derived tetrahydro-beta-carbolines in commercial sausages. J Agric Food Chem 52:2652-2658
49. Herraiz T, Guillén H, Arán VJ, Idle JR, Gonzalez FJ (2006) Comparative aromatic hydroxylation and A-demethylation of MPTP neurotoxin and its analogs, A-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6. Toxicol Appl Pharmacol 216:387-398
50. Herraiz T, Guillén H, Galisteo J (2007) A-methyltetrahydro-beta-carboline analogs of 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin are oxidized to neurotoxic beta-carbo- linium cations by heme peroxidases. Biochem Biophys Res Commun 356:118-123
51. Herraiz T, Guillén H, Arán VJ (2008) Oxidative metabolism of the bioactive and naturally occurring beta-carboline alkaloids, norharman and harman, by human cytochrome P450 enzymes. Chem Res Toxicol 21:2172-2180
52. Herraiz T, Arán VJ, Guillén H (2009) Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO). Free Radic Res 43:975-984
53. Heiraiz T, Gonzalez D, Ancín-Azpilicueta C, Arán VJ, Guillén H (2010) Beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem Toxicol 48:839-845
54. Honecker H, Rommelspacher H (1978) Tetrahydronorharmane (Tetrahydro-beta-carboline), a physiologically occurring compound of indole metabolism. Naunyn Schmiedebergs Arch Pharmacol 305:135-141
55. Janetzky B, God R, Bringmann G, Reichmann H (1995) 1-Trichloromethyl-1,2,3,4-tetrahydro- beta-carboline, a new inhibitor of complex I. J Neural Transm Suppl 46:265-273
56. Kuhn W, Muller T, Grosse H, Dierks T, Rommelspacher H (1995a) Plasma levels of the beta-car- bolines harman and norharman in Parkinson's disease. Acta Neurol Scand 92:451-454
57. Kuhn W, Muller T, Grosse H, Rommelspacher H (1995b) Plasma harman and norharman in Parkinson's disease. J Neural Transm Suppl 46:291-295
58. Kuhn W, Muller T, Grosse H, Rommelspacher H (1996) Elevated levels of harman and norharman in cerebrospinal fluid of parkinsonian patients. J Neural Transm 103:1435-1440
59. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980
60. Lee CS, Han ES, Jang YY, Han JH, Ha HW, Kim DE (2000) Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells. J Neurochem 75:521-531
61. Leuschner J, Beuscher N, Zimmermann T, Schurer M, Schulz HU, Jeromin J, Ritter H (1998) Investigation on plasma levels of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta- carboline after oral administration of chloral hydrate in man. Arzneimittelforschung 48:1-5
62. Lorenc-Koci E, Rommelspacher H, Schulze G, Wernicke C, Kuter K, Smialowska M, Wieronska J, Zieba B, Ossowska K (2006) Parkinson's disease-like syndrome in rats induced by 2,9-dim- ethyl-beta-carbolinium ion, a beta-carboline occurring in the human brain. Behav Pharmacol 17:463-473
63. Louis ED, Zheng W, Jurewicz EC, Watner D, Chen J, Factor-Litvak P, Parides M (2002) Elevation of blood beta-carboline alkaloids in essential tremor. Neurology 59:1940-1944
64. Manabe S, Yuan J, Takahashi T, Urban RC (1996) Age-related accumulation of 1-methyl-1,2,3,4- tetrahydro-beta-carboline-3-carboxylic acid in human lens. Exp Eye Res 63:179-186
65. Mann A, Tyndale RF (2010) Cytochrome P450 2D6 enzyme neuroprotects against 1-methyl-4- phenylpyridinium toxicity in SH-SY5Y neuronal cells. Eur J Neurosci 31:1185-1193
66. Mann A, Miksys S, Lee A, Mash DC, Tyndale RF (2008) Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment. Neuropharmacology 55:1147-1155
67. Matoh N, Tanaka S, Takehashi M, Banasik M, Stedeford T, Masliah E, Suzuki S, Nishimura Y, Ueda K (2003) Overexpression of CYP2D6 attenuates the toxicity of MPP+ in actively dividing and differentiated PC12 cells. Gene Expr 11:117-124
68. Matsubara K, Collins MA, Neafsey EJ (1992a) Mono-A-methylation of 1,2,3,4-tetrahydro- beta- carbolines in brain cytosol. Absence of indole methylation. J Neurochem 59:505-510
69. Matsubara K, Neafsey EJ, Collins MA (1992b) Novel S-adenosylmethionine-dependent indole-A- methylation of beta-carbolines in brain particulate fractions. J Neurochem 59:511-518
70. Matsubara K, Collins MA, Akane A, Ikebuchi J, Neafsey EJ, Kagawa M, Shiono H (1993) Potential bioactivated neurotoxicants, A-methylated beta-carbolinium ions, are present in human brain. Brain Res 610:90-96
71. Matsubara K, Kobayashi S, Kobayashi Y, Yamashita K, Koide H, Hatta M, Iwamoto K, Tanaka O, Kimura K (1995) Beta-carbolinium cations, endogenous MPP+ analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease. Neurology 45:2240-2245
72. Matsubara K, Gonda T, Sawada H, Uezono T, Kobayashi Y, Kawamura T, Ohtaki K, Kimura K, Akaike A (1998a) Endogenously occurring beta-carboline induces parkinsonism in nonprimate animals: A possible causative protoxin in idiopathic Parkinson's disease. J Neurochem 70:727-735
73. Matsubara K, Senda T, Uezono T, Fukushima S, Ohta S, Igarashi K, Naoi M, Yamashita Y, Ohtaki K, Hayase N, Akutsu S, Kimura K (1998b) Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter. Eur J Pharmacol 348:77-84
74. Matsubara K, Senda T, Uezono T, Awaya T, Ogawa S, Chiba K, Shimizu K, Hayase N, Kimura K (2001) L-deprenyl prevents the cell hypoxia induced by dopaminergic neurotoxins, MPP+ and beta-carbolinium: a microdialysis study in rats. Neurosci Lett 302:65-68
75. Matsubara K, Aoyama K, Suno M, Awaya T (2002) A-methylation underlying Parkinson's disease. Neurotoxicol Teratol 24:593-598
76. Musshoff F, Daldrup T, Bonte W, Leitner A, Lesch OM (1996) Formaldehyde-derived tetrahy- droisoquinolines and tetrahydro-beta-carbolines in human urine. J Chromatogr B 683:163-176
77. Neafsey EJ, Drucker G, Raikoff K, Collins MA (1989) Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a beta-carbolinium analog of N-methyl-4- phenylpyridinium ion (MPP+). Neurosci Lett 105:344-349
78. + cause nigrostriatal toxicity after substantia nigra injections in rats. Brain Res 675:279-288
79. Östergren A, Annas A, Skog K, Lindquist NG, Brittebo EB (2004) Long-term retention of neurotoxic beta-carbolines in brain neuromelanin. J Neural Transm 111:141-157
80. Östergren A, Fredriksson A, Brittebo EB (2006) Norharman-induced motoric impairment in mice: neurodegeneration and glial activation in substantia nigra. J Neural Transm 113:313-329
81. Östergren A, Lindquist NG, Brittebo EB (2007) Differential effects of dopamine melanin on nor- harman-induced toxicity in PC12 cells. J Neural Transm 114:909-918
82. Parker CA, Anderson NJ, Robinson ESJ, Price R, Tyacke RJ, Husbands SM, Dillon MP, Eglen RM, Hudson AL, Nutt DJ, Crump MP, Crosby J (2004) Harmane and harmalan are bioactive components of classical clonidine-displacing substance. Biochemistry 43:16385-16392
83. Parsons RB, Smith SW, Waring RH, Williams AC, Ramsden DB (2003) High expression of nicotinamide A-methyltransferase in patients with idiopathic Parkinson's disease. Neurosci Lett 342:13-16
84. Pavlovic S, Schulze G, Wernicke C, Bonnet R, Gille G, Badiali L, Kaminska A, Lorenc-Koci E, Ossowska K, Rommelspacher H (2006) 2,9-Dimethyl-beta-carbolinium, a neurotoxin occurring in human brain, is a potent inducer of apoptosis as 1-methyl-4-phenylpyridinium. Neuroscience 139:1525-1537
85. Perry TL, Yong VW, Wall RA, Jones K (1986) Paraquat and two endogenous analogs of the neurotoxic substance A-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse. Neurosci Lett 69:285-289
86. Pfau W, Skog K (2004) Exposure to beta-carbolines norharman and harman. J Chromatogr B 802:115-126
87. Przedborski S, Vila M (2003) The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model. A tool to explore the pathogenesis of Parkinson's disease. Ann N Y Acad Sci 991:189-198
88. +) analogs and their energized accumulation by mitochondria. Proc Natl Acad Sci USA 86:9168-9172
89. Riederer P, Foley P, Bringmann G, Feineis D, Bruckner R, Gerlach M (2002) Biochemical and pharmacological characterization of 1-trichloromethyl -1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin? Eur J Pharmacol 442:1-16
90. Robinson ESJ, Anderson NJ, Crosby J, Nutt DJ, Hudson AL (2003) Endogenous beta-carbolines as clonidine-displacing substances. Ann N Y Acad Sci 1009:157-166
91. Rollema H, Booth RG, Castagnoli N (1988) In vivo dopaminergic neurotoxicity of the 2-beta- methylcarbolinium ion, a potential endogenous MPP+ analog. Eur J Pharmacol 153:131-134
92. Rommelspacher H, Honecker H, Meinke B (1979) Biochemical and pharmacological studies with 6-hydroxytetrahydronorharmane (6-OH-tetrahydro-beta-carboline), a physiologically occurring metabolite of 5-hydroxytryptamine. Naunyn Schmiedebergs Arch Pharmacol 307:R65
93. Rommelspacher H, Strauss S, Lindemann J (1980) Excretion of tetrahydroharmane and harmane into the urine of man and rat after a load with ethanol. FEBS Lett 109:209-212
94. Rommelspacher H, May T, Susilo R (1991a) Beta-Carbolines and tetrahydroisoquinolines: Detection and function in mammals. Planta Med 57:S85-S92
95. Rommelspacher H, Schmidt LG, May T (1991b) Plasma norharman (beta-carboline) levels are elevated in chronic alcoholics. Alcohol Clin Exp Res 15:553-559
96. Rommelspacher H, May T, Salewski B (1994) Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type-A in rats. Eur J Pharmacol 252:51-59
97. Rommelspacher H, Meier-Henco M, Smolka M, Kloft C (2002) The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets. Eur J Pharmacol 441:115-125
98. Sällström Baum S, Hill R, Rommelspacher H (1996) Harman-induced changes of extracellular concentrations of neurotransmitters in the nucleus accumbens of rats. Eur J Pharmacol 314:75-82
99. Schott Y, Decker M, Rommelspacher H, Lehmann J (2006) 6-Hydroxy- and 6-methoxy-beta-car- bolines as acetyl- and butyrylcholinesterase inhibitors. Bioorg Med Chem Lett 16:5840-5843
100. Spijkerman R, van den Eijnden R, van de Mheen D, Bongers I, Fekkes D (2002) The impact of smoking and drinking on plasma levels of norharman. Eur Neuropsychopharmacol 12:61-71
101. Storch A, Hwang YI, Gearhart DA, Beach JW, Neafsey EJ, Collins MA, Schwarz J (2004a) Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake. J Neurochem 89:685-694
102. Storch A, Ludolph AC, Schwarz J (2004b) Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration. J Neural Transm 111:1267-1286
103. Storch A, Hwang YI, Bringmann G, Feineis D, Ott S, Bruckner R, Schwarz J (2006) Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cells. J Neural Transm 113:1895-1901
104. Totsuka Y, Hada N, Matsumoto K, Kawahara N, Murakami Y, Yokoyama Y, Sugimura T, Wakabayashi K (1998) Structural determination of a mutagenic aminophenylnorharman produced by the co-mutagen norharman with aniline. Carcinogenesis 19:1995-2000
105. Tsuchiya H, Ohtani S, Yamada K, Takagi N, Todoriki H, Hayashi T (1994) Quantitation of urinary-1,2,3,4- tetrahydro-beta-carboline and 1-methyl-1,2,3,4-tetrahydro-ß-carboline by high performance liquid chromatography. J Pharm Sci 83:415-418
106. Wernicke C, Schott Y, Enzensperger C, Schulze G, Lehmann J, Rommelspacher H (2007) Cytotoxicity of beta-carbolines in dopamine transporter expressing cells: Structure-activity relationships. Biochem Pharmacol 74:1065-1077
107. Wernicke C, Hellmann J, Zieba B, Kuter K, Ossowska K, Frenzel M, Dencher NA, Rommelspacher H (2010) 9-Methyl-beta-carboline has restorative effects in an animal model of Parkinson's disease. Pharmacol Rep 62:35-53
108. Yang YJ, Lim SC, Lee MK (2008) The harman and norharman reduced dopamine content and induced cytotoxicity in PC12 cells. Biomol Ther 16:106-112
109. Yu AM, Idle JR, Herraiz T, Küpfer A, Gonzalez FJ (2003a) Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase. Pharmacogenetics 13:307-319
110. Yu AM, Idle JR, Krausz KW, Küpfer A, Gonzalez FJ (2003b) Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine. J Pharmacol Exp Ther 305:315-322